SCHEMBL4575360

SCHEMBL4575360

CC(C)(C)OC(=O)C(C)(C)Oc1cccc(/C=C/N2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.44
▸ PPARG P37231 6/20 0.43
▸ PPARA Q07869 6/20 0.43
▸ NR1H3 Q13133 3/20 0.40
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ BCHE P06276 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ SENP6 Q9GZR1 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575361 1.00 FBP1 (0.44) FBP1PPARGPPARANR1H3HSP90AA1
SCHEMBL6779926 0.87 PPARG (0.54) FBP1PPARGPPARANR1H3BCHE
SCHEMBL6779922 0.87 PPARG (0.54) FBP1PPARGPPARANR1H3BCHE
SCHEMBL4843078 0.80 L3MBTL1 (0.42) NR1H3KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4843067 0.80 L3MBTL1 (0.42) NR1H3KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL29451792 0.79 HSD17B10 (0.41) NR1H3BCHEMEN1KMT2AMAPT
SCHEMBL6359890 0.79 NR1H3 (0.33) NR1H3MEN1KMT2AMAPTALDH1A1
SCHEMBL4841559 0.79 CYSLTR2 (0.44) NR1H3KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4841552 0.79 CYSLTR2 (0.44) NR1H3KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL2441567 0.77 FBP1 (0.48) FBP1PPARGPPARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 — — US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 — — US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 — — EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD FBP1 241/4885PPARG 1/4885PPARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback